The document summarizes an upcoming international conference on pharmaceutics and novel drug delivery systems to be held from March 13-15, 2017 in London. The 3-day conference will include 300+ attendees from industry and academia participating in 12+ keynote lectures, 5+ plenary lectures, and 14 tracks covering various topics on drug delivery innovations. It encourages participants to register by providing information on sponsorship opportunities, pricing, and nearby hotel accommodations.
Our recent project developed a novel 4P-based (product, price, promotion, place) marketing strategy for the local cosmetics sector in Taiwan's biotech industry. A questionnaire was distributed to cosmetic manufacturers and the results were analyzed using factor analysis. The proposed 4P strategy can help cosmetic manufacturers increase market share and provide a more objective outcome for decision-making than conventional approaches. It also offers guidelines for an efficient marketing policy to decrease costs and improve competitiveness for Taiwan's biotech industry.
Project description future challenges and focus group on pharmaceutical suppl...Dr. Hannes Hofmann
Together with Professor Dr. Constantin Blome (University of Sussex, UK) and Professor Dr. Michael Henke (Fraunhofer IML Dortmund/TU Dortmund, Germany), we conduct an international study on the future of pharmaceutical supply chains.
Based on your personal expertise and experience, we chose to contact you to share your judgments about how certain trends over the next 10 years will affect pharmaceutical supply chains.
With this research project we aim to achieve two goals:
1) Based on expert judgments we will compile a management report illustrating key challenges and prospects for pharmaceutical supply chains in 2025.
2) A Focus Group of practitioners and academia will be established to share expert views on upcoming trends and to develop joint solutions to master upcoming challenges.
Of course, your personal and your company’s identity will not be disclosed and all information will be aggregated.
OrganicDataNetwork Comprehensiveness & Compatibility of different organic mar...Raffaele Zanoli
The presentation is an abridged compilation of the following OrganicDataNetwork publications:
Feldmann, C. and Hamm, U. (2013). Executive summary report on the comprehensiveness and compatibility of organic market data collection methods. University of Kassel, Witzenhausen (D3.2) available at http://orgprints.org/23011/.
Feldmann, C. and Hamm, U. (2013). Report on collection methods: Classification of data collection methods University of Kassel, Witzenhausen (D3.1) available at http://orgprints.org/23010/.
This document contains information about the International Conference and Exhibition on Nanomedicine and Drug Delivery that will take place from May 29-31, 2017 in Osaka, Japan. It includes the tentative program agenda, speaker biographies, organizing committee members, and registration information. The conference will feature keynote lectures, interactive sessions, workshops, and tracks on topics related to nanomedicine and drug delivery over the three-day event.
This is my own ppt...which was created for my seminar use and this is very useful to everyone and can use very efficiently...Very useful content is placed in this presentation
The document discusses dye sensitized solar cells (DSSCs) and describes methods to improve their efficiency through controlling the morphology of the TiO2 electrodes. It summarizes a study that demonstrated tuning the pore size of mesoporous TiO2 thin film electrodes from 6-50 nm using chemical modification techniques. This allowed for higher dye adsorption and electron transport, improving the energy conversion efficiency of DSSCs. The document also reports methods to synthesize ordered mesoporous TiO2 thin films using templates and discusses their characterization and potential use in DSSCs.
Growth of Nanomedicine Market in a new 2016 reportPete Jones
The document is a 112-page market research report on the global nanomedicine industry in 2016. It provides an overview of the nanomedicine market, including definitions, classifications, applications, and industry chain structure. The report analyzes the 2015 market share and provides forecasts for the global and regional nanomedicine markets from 2016-2021. It also profiles major companies in the nanomedicine industry and includes a detailed table of contents covering the industry's manufacturing costs, applications, developments, and more. The complete report is available for purchase starting at US$3500.
The document discusses nanomedicine, which uses materials at the nano-scale to enable early disease detection, prevention, and improved diagnosis and treatment. It can monitor, repair, construct and control human biological systems at the molecular level using engineered nanodevices. Nanomedicine has applications in diagnostics, therapeutics, and regenerative medicine. It offers advantages like targeted drug delivery, fewer side effects, and easier detection and treatment, but also has disadvantages like high costs and implementation difficulties. The document concludes that advances in nanotechnology are beginning to change medicine and nanotherapies could be more economical, effective, and safe in the long run.
Our recent project developed a novel 4P-based (product, price, promotion, place) marketing strategy for the local cosmetics sector in Taiwan's biotech industry. A questionnaire was distributed to cosmetic manufacturers and the results were analyzed using factor analysis. The proposed 4P strategy can help cosmetic manufacturers increase market share and provide a more objective outcome for decision-making than conventional approaches. It also offers guidelines for an efficient marketing policy to decrease costs and improve competitiveness for Taiwan's biotech industry.
Project description future challenges and focus group on pharmaceutical suppl...Dr. Hannes Hofmann
Together with Professor Dr. Constantin Blome (University of Sussex, UK) and Professor Dr. Michael Henke (Fraunhofer IML Dortmund/TU Dortmund, Germany), we conduct an international study on the future of pharmaceutical supply chains.
Based on your personal expertise and experience, we chose to contact you to share your judgments about how certain trends over the next 10 years will affect pharmaceutical supply chains.
With this research project we aim to achieve two goals:
1) Based on expert judgments we will compile a management report illustrating key challenges and prospects for pharmaceutical supply chains in 2025.
2) A Focus Group of practitioners and academia will be established to share expert views on upcoming trends and to develop joint solutions to master upcoming challenges.
Of course, your personal and your company’s identity will not be disclosed and all information will be aggregated.
OrganicDataNetwork Comprehensiveness & Compatibility of different organic mar...Raffaele Zanoli
The presentation is an abridged compilation of the following OrganicDataNetwork publications:
Feldmann, C. and Hamm, U. (2013). Executive summary report on the comprehensiveness and compatibility of organic market data collection methods. University of Kassel, Witzenhausen (D3.2) available at http://orgprints.org/23011/.
Feldmann, C. and Hamm, U. (2013). Report on collection methods: Classification of data collection methods University of Kassel, Witzenhausen (D3.1) available at http://orgprints.org/23010/.
This document contains information about the International Conference and Exhibition on Nanomedicine and Drug Delivery that will take place from May 29-31, 2017 in Osaka, Japan. It includes the tentative program agenda, speaker biographies, organizing committee members, and registration information. The conference will feature keynote lectures, interactive sessions, workshops, and tracks on topics related to nanomedicine and drug delivery over the three-day event.
This is my own ppt...which was created for my seminar use and this is very useful to everyone and can use very efficiently...Very useful content is placed in this presentation
The document discusses dye sensitized solar cells (DSSCs) and describes methods to improve their efficiency through controlling the morphology of the TiO2 electrodes. It summarizes a study that demonstrated tuning the pore size of mesoporous TiO2 thin film electrodes from 6-50 nm using chemical modification techniques. This allowed for higher dye adsorption and electron transport, improving the energy conversion efficiency of DSSCs. The document also reports methods to synthesize ordered mesoporous TiO2 thin films using templates and discusses their characterization and potential use in DSSCs.
Growth of Nanomedicine Market in a new 2016 reportPete Jones
The document is a 112-page market research report on the global nanomedicine industry in 2016. It provides an overview of the nanomedicine market, including definitions, classifications, applications, and industry chain structure. The report analyzes the 2015 market share and provides forecasts for the global and regional nanomedicine markets from 2016-2021. It also profiles major companies in the nanomedicine industry and includes a detailed table of contents covering the industry's manufacturing costs, applications, developments, and more. The complete report is available for purchase starting at US$3500.
The document discusses nanomedicine, which uses materials at the nano-scale to enable early disease detection, prevention, and improved diagnosis and treatment. It can monitor, repair, construct and control human biological systems at the molecular level using engineered nanodevices. Nanomedicine has applications in diagnostics, therapeutics, and regenerative medicine. It offers advantages like targeted drug delivery, fewer side effects, and easier detection and treatment, but also has disadvantages like high costs and implementation difficulties. The document concludes that advances in nanotechnology are beginning to change medicine and nanotherapies could be more economical, effective, and safe in the long run.
Nanotechnology is the purposeful manipulation of matter on an atomic scale. Materials created in this manner often exhibit unique physical and chemical properties, which have useful applications in various industries. A growing use for some types of engineered nanomaterials is in the area of environmental remediation, termed nanoremediation. While this technique appears to be effective for cleanup, there are still many unanswered questions regarding its long-term impact to environmental quality and human health. No long-term studies exist regarding the potential environmental impact of nanoremediation. While animal studies have shown the potential for adverse health effects, limited data regarding human health are available. The US Environmental Protection Agency is currently adapting existing regulations to cover the use of nanomaterials in remediation, but this approach is limited. Many questions still remain regarding fate and transport, verification of clean-up, and potential occupational and community exposures.
RECENT ADVANCES IN MICRO AND NANO DRUG DELIVERY SYSTEMSVijitha J
This document discusses recent advances in micro and nano drug delivery systems. It describes how nanomedicine uses nanoparticles smaller than 100nm for diagnosis, treatment, and prevention of diseases. Various types of nanoparticles are discussed for drug delivery, including metal-based, lipid-based, polymer-based, and biological nanoparticles. Specific examples provided include gold nanoparticles that can self-assemble into plasmonic vesicles for stimuli-responsive drug release, silica-gold nanoshells for thermal ablation of cancer cells, and liposomes for encapsulation of both hydrophobic and hydrophilic drugs. The mechanisms of polymeric nanoparticles, lipid nanoparticles, and chitosan carriers for drug delivery are also summarized. The document concludes by discussing the potential of nanoparticles for
This document defines biomaterials as substances engineered to interact with biological systems for medical purposes. It classifies biomaterials as hard or flexible and discusses important factors like biocompatibility. Applications of biomaterials include pacemakers, dental implants, artificial joints, and contact lenses. Common biomaterials are polymers, ceramics, metals, and alloys which are used in devices like heart valves, artificial tissues, dental implants, and intraocular lenses.
Novel drug delivery system nanotechnologyShamal Ghosh
This presentation discusses novel drug delivery systems using nanotechnology. It begins by introducing drug delivery and targeted drug delivery. It then discusses nanotechnology and some fields that use nanotechnology, such as medicine, energy, information and communication, and heavy industries. The presentation goes on to describe dendrimers, liposomes, and micelles as nanocarriers for drug delivery and their mechanisms. It discusses how these nanocarriers can improve drug solubility, stability, targeting ability, and reduce toxicity for delivering drugs to treat diseases.
1. The document discusses the use of nanotechnology in various medical applications including drug discovery, delivery, and tissue engineering.
2. Nanoparticles, nanotubes, and other nanostructures are being used to develop more targeted drug therapies and more effective medical implants and devices.
3. Nanotechnology is also discussed as having applications in surgery, diagnostics, and cancer treatment by enabling earlier detection and more precise interventions.
Biomaterials are materials that are used in medical devices and implants that are introduced into the human body. They must be biocompatible, meaning they are compatible with and accepted by the body, and must withstand the body's internal conditions like temperature, pH levels, and corrosive fluids. Common biomaterials include polymers like nylon and silicone, ceramics like aluminum oxide, and metals like titanium alloys. Examples of biomaterials in use include pacemakers which use titanium casings and polyurethane insulation, contact lenses made of soft hydrogel plastics, knee implants made of plastics and metals, and the latest artificial hearts which are made of titanium and special plastics.
Controlled Release Drug Delivery Systems - An IntroductionSuraj Choudhary
This document discusses controlled release drug delivery systems (CRDDS). It begins by defining CRDDS and comparing them to conventional drug delivery systems. CRDDS aim to control the rate, localization, and targeting of drug action in the body. The document then covers the history and classifications of CRDDS, including classifications based on technical sophistication, administration route, and other criteria. Various design considerations for CRDDS are outlined as well. Recent innovations in oral, nasal, ocular and transdermal delivery are also mentioned.
This document discusses the history and development of biomaterials. It begins by describing early biomaterials like gold, iron, brass and glass that were used by physicians with little consideration of material properties. The document then outlines major developments in biomaterials from the 1860s to the present day for applications like orthopedics, dental, cardiovascular and others. Key points covered include the regulatory framework for biomaterials and medical devices as well as current and future directions in the field.
Targeted drug delivery systems aim to increase the concentration of drugs in specific tissues while reducing side effects. The document discusses various drug delivery carrier technologies including lipid-based carriers like liposomes, polymer-based carriers, inorganic nanoparticles, magnetic particles, nucleic acid/peptide carriers, and cell-based delivery systems. It also covers the technology value chain and key innovations in targeted delivery systems for diseases like cancer and neurological disorders. While targeted delivery offers advantages, challenges remain around costs, long-term effects, and developing multi-pronged targeting approaches.
Nanotechnology has applications in the medical field through the use of nano-scale devices called nanorobots. These nanorobots can operate at the scale of individual atoms and molecules to diagnose and treat diseases. Some potential uses include imaging tumors at the nano-scale, targeted drug delivery to specific locations in the body, destruction of cancer cells through generation of radiation or acoustic signals, repair of damaged tissues, and detection and removal of viruses. While promising advances, nanomedicine also faces challenges of high costs and difficulties in practical implementation.
The document discusses biomaterials, which are materials used in medical applications that interact with biological systems. It defines biomaterials and outlines their history, characteristics, examples of applications like implants and grafts, challenges, and future potential. Key biomaterial properties include biocompatibility, mechanical compatibility with tissues, and ability to perform specific functions. Common biomaterials are metals, ceramics, polymers, and composites used in devices like heart valves, dental implants, and orthopedic implants.
Dr. Maulik Patel's research focuses on developing new drug delivery systems to more selectively target drugs to the site of action. His goals are to increase bioavailability, provide controlled delivery, transport drugs intact to the target site while avoiding healthy tissue, and ensure stable delivery under physiological conditions. He examines various polymer-based formulations, micelles, liposomes, and nanotechnology approaches to better control drug release kinetics and targeting.
Controlled Release Drug Delivery Systems - Types, Methods and ApplicationsSuraj Choudhary
This document discusses factors affecting the design of controlled release drug delivery systems (CRDDS). It outlines several key considerations for CRDDS design including selection of the drug candidate, medical and biological rationale, and physicochemical properties. It also discusses important physicochemical factors such as solubility, partition coefficient, molecular size and diffusivity, dose size, complexation, ionization constant, drug stability, and protein binding that influence CRDDS design. Finally, it briefly describes dissolution-controlled and diffusion-controlled release approaches for developing CRDDS.
Nanotechnology involves manipulating matter at the atomic or molecular scale, typically 100 nanometers or smaller. Richard Feynman first suggested the possibility of nanomachines in 1959. Albert Hibbs later suggested using nanomachines for medical purposes like surgery. Current applications of nanotechnology in medicine include more targeted drug delivery, cancer treatment using gold nanoparticles, microsurgery using nanoscale instruments, medical robotics, and tissue engineering. While nanomedicine holds promise, it also raises social, economic, ethical, and safety issues that warrant careful consideration and oversight to ensure its safe and equitable development and use.
This document discusses different types of controlled release drug delivery systems. It describes rate preprogrammed systems which release drugs at predetermined rates, including polymer membrane and matrix diffusion systems. It also covers feedback regulated systems where drug release is activated by biological triggers, including bioerosion, bioresponsive, and self-regulating systems. The advantages of controlled release include improved patient convenience and safety, while disadvantages can include reduced systemic availability and difficulty retrieving drugs in emergencies.
Biomaterials are any substances used in medical devices and implants that interact with biological systems. They include metals, ceramics, polymers, and composites. Biomaterials must be biocompatible and not elicit negative host tissue responses. Newer generations of biomaterials aim to regenerate tissues through cell-material interactions and tissue engineering approaches. The biomaterials field involves many disciplines working to develop safer and more effective materials for applications such as orthopedic and dental implants, vascular grafts, drug delivery devices, and more. Key challenges include replicating complex tissue structures in vitro and improving biocompatibility.
This document provides an agenda for the 13th Annual Conference on Controlled Release to be held on April 18-19, 2016 in London. The conference will focus on uniting innovation and science to improve controlled release formulation and delivery for next generation drugs. It will feature speakers from pharmaceutical companies and regulatory agencies discussing topics like the use of Quality by Design in controlled release, innovations in oral and parenteral controlled release technologies, and formulation challenges. The document also lists upcoming conferences held by SMi on other pharmaceutical topics in 2016.
This document outlines a presentation on innovative strategies to accelerate drug development. It discusses Pfizer's locations in the UK and facilities for research, manufacturing, and commercial operations. Predictive science approaches using advanced data and technologies are described to enable accelerated development from molecule to medicine. Continuous manufacturing platforms and modular facilities are presented as ways to improve efficiency.
Nanotechnology is the purposeful manipulation of matter on an atomic scale. Materials created in this manner often exhibit unique physical and chemical properties, which have useful applications in various industries. A growing use for some types of engineered nanomaterials is in the area of environmental remediation, termed nanoremediation. While this technique appears to be effective for cleanup, there are still many unanswered questions regarding its long-term impact to environmental quality and human health. No long-term studies exist regarding the potential environmental impact of nanoremediation. While animal studies have shown the potential for adverse health effects, limited data regarding human health are available. The US Environmental Protection Agency is currently adapting existing regulations to cover the use of nanomaterials in remediation, but this approach is limited. Many questions still remain regarding fate and transport, verification of clean-up, and potential occupational and community exposures.
RECENT ADVANCES IN MICRO AND NANO DRUG DELIVERY SYSTEMSVijitha J
This document discusses recent advances in micro and nano drug delivery systems. It describes how nanomedicine uses nanoparticles smaller than 100nm for diagnosis, treatment, and prevention of diseases. Various types of nanoparticles are discussed for drug delivery, including metal-based, lipid-based, polymer-based, and biological nanoparticles. Specific examples provided include gold nanoparticles that can self-assemble into plasmonic vesicles for stimuli-responsive drug release, silica-gold nanoshells for thermal ablation of cancer cells, and liposomes for encapsulation of both hydrophobic and hydrophilic drugs. The mechanisms of polymeric nanoparticles, lipid nanoparticles, and chitosan carriers for drug delivery are also summarized. The document concludes by discussing the potential of nanoparticles for
This document defines biomaterials as substances engineered to interact with biological systems for medical purposes. It classifies biomaterials as hard or flexible and discusses important factors like biocompatibility. Applications of biomaterials include pacemakers, dental implants, artificial joints, and contact lenses. Common biomaterials are polymers, ceramics, metals, and alloys which are used in devices like heart valves, artificial tissues, dental implants, and intraocular lenses.
Novel drug delivery system nanotechnologyShamal Ghosh
This presentation discusses novel drug delivery systems using nanotechnology. It begins by introducing drug delivery and targeted drug delivery. It then discusses nanotechnology and some fields that use nanotechnology, such as medicine, energy, information and communication, and heavy industries. The presentation goes on to describe dendrimers, liposomes, and micelles as nanocarriers for drug delivery and their mechanisms. It discusses how these nanocarriers can improve drug solubility, stability, targeting ability, and reduce toxicity for delivering drugs to treat diseases.
1. The document discusses the use of nanotechnology in various medical applications including drug discovery, delivery, and tissue engineering.
2. Nanoparticles, nanotubes, and other nanostructures are being used to develop more targeted drug therapies and more effective medical implants and devices.
3. Nanotechnology is also discussed as having applications in surgery, diagnostics, and cancer treatment by enabling earlier detection and more precise interventions.
Biomaterials are materials that are used in medical devices and implants that are introduced into the human body. They must be biocompatible, meaning they are compatible with and accepted by the body, and must withstand the body's internal conditions like temperature, pH levels, and corrosive fluids. Common biomaterials include polymers like nylon and silicone, ceramics like aluminum oxide, and metals like titanium alloys. Examples of biomaterials in use include pacemakers which use titanium casings and polyurethane insulation, contact lenses made of soft hydrogel plastics, knee implants made of plastics and metals, and the latest artificial hearts which are made of titanium and special plastics.
Controlled Release Drug Delivery Systems - An IntroductionSuraj Choudhary
This document discusses controlled release drug delivery systems (CRDDS). It begins by defining CRDDS and comparing them to conventional drug delivery systems. CRDDS aim to control the rate, localization, and targeting of drug action in the body. The document then covers the history and classifications of CRDDS, including classifications based on technical sophistication, administration route, and other criteria. Various design considerations for CRDDS are outlined as well. Recent innovations in oral, nasal, ocular and transdermal delivery are also mentioned.
This document discusses the history and development of biomaterials. It begins by describing early biomaterials like gold, iron, brass and glass that were used by physicians with little consideration of material properties. The document then outlines major developments in biomaterials from the 1860s to the present day for applications like orthopedics, dental, cardiovascular and others. Key points covered include the regulatory framework for biomaterials and medical devices as well as current and future directions in the field.
Targeted drug delivery systems aim to increase the concentration of drugs in specific tissues while reducing side effects. The document discusses various drug delivery carrier technologies including lipid-based carriers like liposomes, polymer-based carriers, inorganic nanoparticles, magnetic particles, nucleic acid/peptide carriers, and cell-based delivery systems. It also covers the technology value chain and key innovations in targeted delivery systems for diseases like cancer and neurological disorders. While targeted delivery offers advantages, challenges remain around costs, long-term effects, and developing multi-pronged targeting approaches.
Nanotechnology has applications in the medical field through the use of nano-scale devices called nanorobots. These nanorobots can operate at the scale of individual atoms and molecules to diagnose and treat diseases. Some potential uses include imaging tumors at the nano-scale, targeted drug delivery to specific locations in the body, destruction of cancer cells through generation of radiation or acoustic signals, repair of damaged tissues, and detection and removal of viruses. While promising advances, nanomedicine also faces challenges of high costs and difficulties in practical implementation.
The document discusses biomaterials, which are materials used in medical applications that interact with biological systems. It defines biomaterials and outlines their history, characteristics, examples of applications like implants and grafts, challenges, and future potential. Key biomaterial properties include biocompatibility, mechanical compatibility with tissues, and ability to perform specific functions. Common biomaterials are metals, ceramics, polymers, and composites used in devices like heart valves, dental implants, and orthopedic implants.
Dr. Maulik Patel's research focuses on developing new drug delivery systems to more selectively target drugs to the site of action. His goals are to increase bioavailability, provide controlled delivery, transport drugs intact to the target site while avoiding healthy tissue, and ensure stable delivery under physiological conditions. He examines various polymer-based formulations, micelles, liposomes, and nanotechnology approaches to better control drug release kinetics and targeting.
Controlled Release Drug Delivery Systems - Types, Methods and ApplicationsSuraj Choudhary
This document discusses factors affecting the design of controlled release drug delivery systems (CRDDS). It outlines several key considerations for CRDDS design including selection of the drug candidate, medical and biological rationale, and physicochemical properties. It also discusses important physicochemical factors such as solubility, partition coefficient, molecular size and diffusivity, dose size, complexation, ionization constant, drug stability, and protein binding that influence CRDDS design. Finally, it briefly describes dissolution-controlled and diffusion-controlled release approaches for developing CRDDS.
Nanotechnology involves manipulating matter at the atomic or molecular scale, typically 100 nanometers or smaller. Richard Feynman first suggested the possibility of nanomachines in 1959. Albert Hibbs later suggested using nanomachines for medical purposes like surgery. Current applications of nanotechnology in medicine include more targeted drug delivery, cancer treatment using gold nanoparticles, microsurgery using nanoscale instruments, medical robotics, and tissue engineering. While nanomedicine holds promise, it also raises social, economic, ethical, and safety issues that warrant careful consideration and oversight to ensure its safe and equitable development and use.
This document discusses different types of controlled release drug delivery systems. It describes rate preprogrammed systems which release drugs at predetermined rates, including polymer membrane and matrix diffusion systems. It also covers feedback regulated systems where drug release is activated by biological triggers, including bioerosion, bioresponsive, and self-regulating systems. The advantages of controlled release include improved patient convenience and safety, while disadvantages can include reduced systemic availability and difficulty retrieving drugs in emergencies.
Biomaterials are any substances used in medical devices and implants that interact with biological systems. They include metals, ceramics, polymers, and composites. Biomaterials must be biocompatible and not elicit negative host tissue responses. Newer generations of biomaterials aim to regenerate tissues through cell-material interactions and tissue engineering approaches. The biomaterials field involves many disciplines working to develop safer and more effective materials for applications such as orthopedic and dental implants, vascular grafts, drug delivery devices, and more. Key challenges include replicating complex tissue structures in vitro and improving biocompatibility.
This document provides an agenda for the 13th Annual Conference on Controlled Release to be held on April 18-19, 2016 in London. The conference will focus on uniting innovation and science to improve controlled release formulation and delivery for next generation drugs. It will feature speakers from pharmaceutical companies and regulatory agencies discussing topics like the use of Quality by Design in controlled release, innovations in oral and parenteral controlled release technologies, and formulation challenges. The document also lists upcoming conferences held by SMi on other pharmaceutical topics in 2016.
This document outlines a presentation on innovative strategies to accelerate drug development. It discusses Pfizer's locations in the UK and facilities for research, manufacturing, and commercial operations. Predictive science approaches using advanced data and technologies are described to enable accelerated development from molecule to medicine. Continuous manufacturing platforms and modular facilities are presented as ways to improve efficiency.
Medical nanotechnology 2017 sponsorshipJasmin Keith
SHORT DESCRIPTION – Global Experts Meeting on “15th World Medical Nanotechnology Congress & Expo” is to be held in Osaka, Japan during October 18, 19 of 2017 Organized by Conference series LLC. It will bring together world-class professors, scientists, academic scholars, and doctors, engineers, students, delegates to discuss the current developments, renewable materials and New Medical technologies on in the field of Nanotechnology from all around the world.
The International Food Information Service (IFIS) is an established provider of food science and technology information that collects, manages, and distributes information to industry professionals. IFIS produces the Food Science and Technology Abstracts database, the world's largest database covering food science. IFIS's mission is to communicate food science knowledge globally to stimulate education, research, and training for humanity's benefit. IFIS helps food companies stay informed of advances, support R&D, ensure food safety, and bring new products to market.
The document summarizes the 14th Annual PepTalk conference organized by Cambridge Healthtech Institute. The conference will be held from January 19-23, 2015 in San Diego, CA and will feature over 1,200 international participants from industry, academia and government. It will include 20 conferences, 13 short courses, 325 speaker presentations, 80 roundtable discussions, 100 exhibitors and 125 research posters on topics related to protein engineering, antibody therapeutics, formulation, production, analytics and purification. A keynote speech will be given by Dr. John Yates from The Scripps Research Institute on advances in proteomics. The conference provides numerous opportunities for education, innovation and networking in the protein science field.
Our first webinar in the MDC Connects Series 2021 | A Guide to Complex Medicines.
This slide deck takes a closer look at the state of play for Complex Medicine and highlights the potential opportunity for the UK.
Prof Peter Simpson, Medicines Discovery Catapult
SMi Group's 9th annual Pre-filled Syringes Europe 2017 Dale Butler
This document provides information on two half-day pre-conference workshops on January 17th, 2017 regarding pre-filled syringes in London, UK. Workshop A from 8:30-12:30 will explore how personalized medicine, enhanced patient experience, and improved outcomes will drive the development of digital therapy management ecosystems and how this will impact future parenteral drug delivery devices. Workshop B from 13:30-18:15 will examine regulatory challenges at the interface of medicines and medical devices. Both workshops aim to provide insights on these important topics for professionals in the pre-filled syringes industry.
This document provides information on the 13th Annual Conference on Controlled Release taking place on April 18-19, 2016 in London. The conference will feature sessions on quality by design principles in controlled release drug development, innovations in controlled release delivery methods, and regulatory perspectives on controlled release systems. It will also include two half-day post-conference workshops on April 20th focusing on QbD-driven controlled release design and exploring various controlled release drug delivery methods. The conference aims to bring together industry and academic experts to discuss advances in controlled release formulation and delivery.
CHI’s Inaugural Biologics Formulation and Delivery Summit will provide a forum for focused discussions on current challenges and opportunities in delivery of biotherapeutics. This 2-part summit will discuss various formulation and device-based approaches for designing physiologically relevant, patient friendly, targeted biologics products.
Part 1: Formulation Strategies for Improved Delivery of Biologics (May 5-6)
Part 2: New Technologies for Biologics Delivery and Targeting (May 6-7)
Prof Clive Badman OBE
Presentation at EIPG - Royal Pharmaceutical Society Scientific Symposium "Advances in Technology Impacting the Pharmaceutical Industry" at the University of Strathclyde, Glasgow 2015.
SMi Group's Adaptive Designs in Clinical Trials conferenceDale Butler
This document summarizes an upcoming conference on adaptive designs in clinical trials taking place from April 20-21, 2015 in London. The conference will focus on topics such as Bayesian adaptive designs, subgroup selection in clinical trials, integrating real-world patient data into adaptive trials, and designing biomarker-driven multi-arm multi-stage cancer trials. Speakers will discuss challenges with adaptive designs and their use in different therapeutic areas like neurodegenerative diseases. Participants can also register for optional half-day workshops on April 22nd focusing on Bayesian clinical trial designs and navigating international regulatory landscapes for adaptive trials.
Discovery on Target 2014 - The Industry's Preeminent Event on Novel Drug TargetsJaime Hodges
Cambridge Healthtech Institute's 12th Annual Discovery on Target will showcase current and emerging “hot” targets for the pharmaceutical industry, October 8 – 10, 2014 in Boston, MA. Spanning three days, the meeting will bring together more than 900 global attendees, including scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations. In 2014 the event is comprised of 14 conference tracks which include Epigenetic Readers, Ubiquitin Proteasome, Big Data Discovery, GPCR Drug Discovery, RNAi-Screens-Functional-Genomics, PPI Targets, Protein-Targets, Histone-Methyltransferases-Demethylases, Drug Transporters, Maximizing Efficiency, GPCR Therapeutics, Genomics Screening, Cancer Metabolism and Membrane Production. The 2014 event will offer 200+ scientific presentations across 14 conference tracks, 1 Symposium and 15 conference short courses, 40+ interactive breakout discussion groups, an exhibit hall of 40+ companies, and dedicated poster viewing and networking sessions.
14th International Conference and Exhibition on Nanomedicine and Pharmaceutic...Evelyn Smith
Conference Series Ltd organizes highly notable pharmaceutical conferences throughout the world. Currently we are bringing forth “14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology” (NanoMed 2018) scheduled to be held during April 09-11, 2018 at Amsterdam, Netherlands. The conference gathers all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Nanotechnology and Drug delivery. The main theme of the conference is “Emerging Importance of Nanomedicine & Nanotechnology to Drive the Pharma Industry”.
NanoPharma 2018 aims to bring together leading academic scientists, researchers, research scholars, fellow key decision makers and experts all-around the Academic Institutions, Healthcare Institutes, Pharmaceutical, Biotech, Biomedical, Formulation scientists and researchers making the congress a perfect platform to share experience, foster collaborations through the research talks & presentations to put forward many thought provoking strategies. It's a perfect stage to brainstorm, discover new ideas, search for new skills and a platform to show your capabilities and discoveries to the world. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions opted in the fields of Nanotechnology and Nanomedicine.
Conference Highlights:
Nanomedicines and Biomedical Applications | Drug Discovery and Designing | Pharmaceutical Nanotechnology | Regenerative Medicine and Tissue Engineering | Drug Delivery Research | Novel Drug Delivery Systems | Nano Pharmaceuticals | Nanobiotechnology | Graphene Medicine | Personalized Nanomedicine | Nanomedicine & Cancer | Pharmaceutical Companies and Markets | Business Opportunities in Nanotechnology
For more details Visit: http://nanotechnology.pharmaceuticalconferences.com/
Drug Delivery & Formulation Summit 2019Diogo Ribeiro
On 19 & 20 September 2019, Munich (Germany) will host the BioTech Pharma Summit: Drug Delivery & Formulation 2019 conference. This year’s event will bring together leaders and senior industry experts in formulation, delivery and product development. Presentations will assess recent technological innovations and discuss their impact on product improvement and patient experience.
SMi Group's Inaugural Big Data in Pharma conferenceDale Butler
This document provides information about a conference on big data in the pharmaceutical industry, including an agenda, speaker details, and workshop information. The two-day conference will focus on how big data can be leveraged to enhance research and development, clinical trials, and real-world evidence generation. Highlights include sessions on personalized medicine, predictive analytics, and social media strategies. Post-conference workshops will discuss the legal aspects of cloud computing and designing studies using big data to support drug development and marketing. The event aims to help pharmaceutical companies exploit big data's potential to create better medicines and new revenue streams.
Presentation carried out during the EMBC'16 conference in Orlando the 17th of August by Paulo Carvalho and Vicente Traver introducing the LINK project and the results of the first iteration with experts about the future opportunities and challenges for research on personalised health care for cardiovascular disease management.
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...Sérgio Sacani
Context. With a mass exceeding several 104 M⊙ and a rich and dense population of massive stars, supermassive young star clusters
represent the most massive star-forming environment that is dominated by the feedback from massive stars and gravitational interactions
among stars.
Aims. In this paper we present the Extended Westerlund 1 and 2 Open Clusters Survey (EWOCS) project, which aims to investigate
the influence of the starburst environment on the formation of stars and planets, and on the evolution of both low and high mass stars.
The primary targets of this project are Westerlund 1 and 2, the closest supermassive star clusters to the Sun.
Methods. The project is based primarily on recent observations conducted with the Chandra and JWST observatories. Specifically,
the Chandra survey of Westerlund 1 consists of 36 new ACIS-I observations, nearly co-pointed, for a total exposure time of 1 Msec.
Additionally, we included 8 archival Chandra/ACIS-S observations. This paper presents the resulting catalog of X-ray sources within
and around Westerlund 1. Sources were detected by combining various existing methods, and photon extraction and source validation
were carried out using the ACIS-Extract software.
Results. The EWOCS X-ray catalog comprises 5963 validated sources out of the 9420 initially provided to ACIS-Extract, reaching a
photon flux threshold of approximately 2 × 10−8 photons cm−2
s
−1
. The X-ray sources exhibit a highly concentrated spatial distribution,
with 1075 sources located within the central 1 arcmin. We have successfully detected X-ray emissions from 126 out of the 166 known
massive stars of the cluster, and we have collected over 71 000 photons from the magnetar CXO J164710.20-455217.
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...University of Maribor
Slides from talk:
Aleš Zamuda: Remote Sensing and Computational, Evolutionary, Supercomputing, and Intelligent Systems.
11th International Conference on Electrical, Electronics and Computer Engineering (IcETRAN), Niš, 3-6 June 2024
Inter-Society Networking Panel GRSS/MTT-S/CIS Panel Session: Promoting Connection and Cooperation
https://www.etran.rs/2024/en/home-english/
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills MN
Travis Hills of Minnesota developed a method to convert waste into high-value dry fertilizer, significantly enriching soil quality. By providing farmers with a valuable resource derived from waste, Travis Hills helps enhance farm profitability while promoting environmental stewardship. Travis Hills' sustainable practices lead to cost savings and increased revenue for farmers by improving resource efficiency and reducing waste.
Describing and Interpreting an Immersive Learning Case with the Immersion Cub...Leonel Morgado
Current descriptions of immersive learning cases are often difficult or impossible to compare. This is due to a myriad of different options on what details to include, which aspects are relevant, and on the descriptive approaches employed. Also, these aspects often combine very specific details with more general guidelines or indicate intents and rationales without clarifying their implementation. In this paper we provide a method to describe immersive learning cases that is structured to enable comparisons, yet flexible enough to allow researchers and practitioners to decide which aspects to include. This method leverages a taxonomy that classifies educational aspects at three levels (uses, practices, and strategies) and then utilizes two frameworks, the Immersive Learning Brain and the Immersion Cube, to enable a structured description and interpretation of immersive learning cases. The method is then demonstrated on a published immersive learning case on training for wind turbine maintenance using virtual reality. Applying the method results in a structured artifact, the Immersive Learning Case Sheet, that tags the case with its proximal uses, practices, and strategies, and refines the free text case description to ensure that matching details are included. This contribution is thus a case description method in support of future comparative research of immersive learning cases. We then discuss how the resulting description and interpretation can be leveraged to change immersion learning cases, by enriching them (considering low-effort changes or additions) or innovating (exploring more challenging avenues of transformation). The method holds significant promise to support better-grounded research in immersive learning.
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxMAGOTI ERNEST
Although Artemia has been known to man for centuries, its use as a food for the culture of larval organisms apparently began only in the 1930s, when several investigators found that it made an excellent food for newly hatched fish larvae (Litvinenko et al., 2023). As aquaculture developed in the 1960s and ‘70s, the use of Artemia also became more widespread, due both to its convenience and to its nutritional value for larval organisms (Arenas-Pardo et al., 2024). The fact that Artemia dormant cysts can be stored for long periods in cans, and then used as an off-the-shelf food requiring only 24 h of incubation makes them the most convenient, least labor-intensive, live food available for aquaculture (Sorgeloos & Roubach, 2021). The nutritional value of Artemia, especially for marine organisms, is not constant, but varies both geographically and temporally. During the last decade, however, both the causes of Artemia nutritional variability and methods to improve poorquality Artemia have been identified (Loufi et al., 2024).
Brine shrimp (Artemia spp.) are used in marine aquaculture worldwide. Annually, more than 2,000 metric tons of dry cysts are used for cultivation of fish, crustacean, and shellfish larva. Brine shrimp are important to aquaculture because newly hatched brine shrimp nauplii (larvae) provide a food source for many fish fry (Mozanzadeh et al., 2021). Culture and harvesting of brine shrimp eggs represents another aspect of the aquaculture industry. Nauplii and metanauplii of Artemia, commonly known as brine shrimp, play a crucial role in aquaculture due to their nutritional value and suitability as live feed for many aquatic species, particularly in larval stages (Sorgeloos & Roubach, 2021).
Current Ms word generated power point presentation covers major details about the micronuclei test. It's significance and assays to conduct it. It is used to detect the micronuclei formation inside the cells of nearly every multicellular organism. It's formation takes place during chromosomal sepration at metaphase.
1. 10th
International Conference & Exhibition on
March 13-15, 2017
London, UK
Pharmaceutics & Novel Drug Delivery Systems
Pharmaceutica 2017
Participation
(70 Industry: 30 Academia)
300+ 12+ 5+ 50+ 3+ 10+ B2BInteractive
Sessions
Keynote
Lectures
Plenary
Lectures
Exhibitors MeetingsWorkshops
ConferenceHighlights:
SPONSORSHIP OPPORTUNITIES
REGISTRATION & PRICING
HOTEL INFORMATION
Pre-Formulation & Formulation Aspects
Pharmacokinetics & Pharmacodynamics in Drugs
Drug Targeting and Design
Routes of Drug Delivery
Nanoparticulate Drug Delivery Systems
Nanotechnology in Drug Delivery
Pharmaceutical Nanotechnology
Smart Drug Delivery Systems
Biomaterials in Drug Delivery
Vaccine Drug Delivery Systems
Medical Devices for Drug Delivery
Peptides and Protein Drug Delivery
Global Drug Delivery Policy
Entrepreneurs Investment Meet
http://novel-drugdelivery-systems.pharmaceuticalconferences.com/
@Pharmaceutica_C
Collaborators
2. ConferenceHighlights:
SPONSORSHIP OPPORTUNITIES
REGISTRATION & PRICING
HOTEL INFORMATION
Pre-Formulation & Formulation Aspects
Pharmacokinetics & Pharmacodynamics in Drugs
Drug Targeting and Design
Routes of Drug Delivery
Nanoparticulate Drug Delivery Systems
Nanotechnology in Drug Delivery
Pharmaceutical Nanotechnology
Smart Drug Delivery Systems
Biomaterials in Drug Delivery
Vaccine Drug Delivery Systems
Medical Devices for Drug Delivery
Peptides and Protein Drug Delivery
Global Drug Delivery Policy
Entrepreneurs Investment Meet
http://novel-drugdelivery-systems.pharmaceuticalconferences.com/
Possessing the right formulation and drug delivery strategy is the foundation of successful drug
development. But how do you achieve this? There are on-going innovations in technology, processes and
partnership types being trialed across the industry. It’s vital to stay abreast of these developments and
look to incorporate selected elements into your existing practice to buoy strengths further and overcome
weaknesses.
Pharmaceutica 2017 provides the perfect platform for just this as an interactive and engaging 3-day
event: unique in format, content, networking and engagement. The event brings together truly innovative
thinkerswhoareleadingthewaythroughtrialingnewdisruptivesolutionsandrethinkingtheconventional
formulation and delivery mind-set.
Pharmaceutica 2017 will help you to better understand how to develop the right formulation and
delivery strategy with a strong scientific, clinical and commercial mind set and how innovative scientific
techniques, emerging technologies and innovative devices can transform formulation and drug delivery.
Regards,
Pharmaceutica 2017 Organizing Committee
Invitation
@Pharmaceutica_C
3. ConferenceHighlights: Tentative Agenda
SPONSORSHIP OPPORTUNITIES
REGISTRATION & PRICING
HOTEL INFORMATION
Pre-Formulation & Formulation Aspects
Pharmacokinetics & Pharmacodynamics in Drugs
Drug Targeting and Design
Routes of Drug Delivery
Nanoparticulate Drug Delivery Systems
Nanotechnology in Drug Delivery
Pharmaceutical Nanotechnology
Smart Drug Delivery Systems
Biomaterials in Drug Delivery
Vaccine Drug Delivery Systems
Medical Devices for Drug Delivery
Peptides and Protein Drug Delivery
Global Drug Delivery Policy
Entrepreneurs Investment Meet
Call for Abstract : http://novel-drugdelivery-systems.pharmaceuticalconferences.com/call-for-abstracts.php
Registration : http://novel-drugdelivery-systems.pharmaceuticalconferences.com/registration.php
Abstract Submission : http://novel-drugdelivery-systems.pharmaceuticalconferences.com/abstract-submission.php
* Exclusive Exhibitor Event
** Networking Event
Note: Conference schedule is subject to change.
Note: Workshops and Symposia slots are available. To book slot for
Workshop and Symposium send us the proposal.
Time Session
08:30-09:30 Registrations
09:30-11:30 Keynote Forum
Group Photo
11:30-11:45 Network & Refreshments Break*
11:45-13:00
Track 1: Pre-Formulation & Formulation Aspects
Track 2: Pharmacokinetics and
Pharmacodynamics in Drugs
13:00-13:45 Lunch Break**
13:45-16:00 Track 3: Drug Targeting and Design
16:00-16:15 Network & Refreshments Break*
16:15-18:00 Track 4: Routes of Drug Delivery
Day Concludes
March 13, 2017 Monday
Time Session
08:30-09:30 Registrations
09:30-10:30 Keynote Forum
10:30-11:30
Track 5: Nanoparticulate Drug
Delivery Systems
11:30-11:45 Network & Refreshments Break*
11:45-13:00
Track 6: Nanotechnology in Drug
Delivery
13:00-13:45 Lunch Break**
13:45-16:00
Track 7: Pharmaceutical
Nanotechnology
16:00-16:15 Network & Refreshments Break*
16:15-18:00
Track 8: Smart Drug Delivery
Systems
16:00-18:00 Poster Presentations
Day Concludes
March 14, 2017 Tuesday
Time Session
09:30-11:30 Track 9: Biomaterials in Drug Delivery
11:30-11:45 Network & Refreshments Break*
11:45-13:00 Track 10: Vaccine Drug Delivery Systems
13:00-13:45 Lunch Break**
13:45-16:00 Track 11: Medical Devices for Drug Delivery
16:00-16:15 Network & Refreshments Break*
16:15-18:00 Track 12: Peptides and Protein Drug Delivery
18:00-18:15 Track 13: Global Drug Delivery Policy
18:15-18:30 Track 14: Entrepreneurs Investment Meet
Award Ceremony
Conference Concludes
March 15, 2017 Wednesday
http://novel-drugdelivery-systems.pharmaceuticalconferences.com/
@Pharmaceutica_C
4. ConferenceHighlights: Keynote Speakers
SPONSORSHIP OPPORTUNITIES
REGISTRATION & PRICING
HOTEL INFORMATION
Pre-Formulation & Formulation Aspects
Pharmacokinetics & Pharmacodynamics in Drugs
Drug Targeting and Design
Routes of Drug Delivery
Nanoparticulate Drug Delivery Systems
Nanotechnology in Drug Delivery
Pharmaceutical Nanotechnology
Smart Drug Delivery Systems
Biomaterials in Drug Delivery
Vaccine Drug Delivery Systems
Medical Devices for Drug Delivery
Peptides and Protein Drug Delivery
Global Drug Delivery Policy
Entrepreneurs Investment Meet
Title: What Properties should Nanopreparations Possess to become Effective
Anticancer Medicines?
Vladimir Torchilin
Director of Center for Pharmaceutical Biotechnology and Nanomedicine
Editor-in-Chief for Drug Delivery, Current Drug Discovery Technologies & OpenNano Journals
Northeastern University, USA
Title: Oral Delivery of Biologics – Back to the Roots
Andreas Bernkop-Schnürch
Professor and Head of Pharmaceutical Technology
CSO at ThioMatrix
University of Innsbruck, Austria
Title: Overcoming Cellular Barriers for Drug Delivery: Opening Endocytic
Gates and Pathways for Intracellular Targetting
Arwyn Tomos Jones
Professor of Membrane Traffic and Drug Delivery
Editorial Board of the Journal of Controlled Release and Membranes
Cardiff School of Pharmacy and Pharmaceutical Sciences
Cardiff University, UK
Title: Age-Related Sight Loss: Novel Drug Delivery Strategies to the Anterior
and Posterior Segments of the Eye
Raid Alany
Editor-in-Chief Pharmaceutical Development and Technology
Head of School of Life Sciences Pharmacy and Chemistry
Kingston University London, UK
Honorary Professor of Pharmacy, The University of Auckland, Auckland, New Zealand
http://novel-drugdelivery-systems.pharmaceuticalconferences.com/
@Pharmaceutica_C
5. ConferenceHighlights: Keynote Speakers
SPONSORSHIP OPPORTUNITIES
REGISTRATION & PRICING
HOTEL INFORMATION
Pre-Formulation & Formulation Aspects
Pharmacokinetics & Pharmacodynamics in Drugs
Drug Targeting and Design
Routes of Drug Delivery
Nanoparticulate Drug Delivery Systems
Nanotechnology in Drug Delivery
Pharmaceutical Nanotechnology
Smart Drug Delivery Systems
Biomaterials in Drug Delivery
Vaccine Drug Delivery Systems
Medical Devices for Drug Delivery
Peptides and Protein Drug Delivery
Global Drug Delivery Policy
Entrepreneurs Investment Meet
Title: Computational Discovery and Experimental Confirmation of TLR9
Receptor Antagonist Leads
Amiram Goldblum
Molecular Modeling and Drug Design, Institute for Drug Research
The Hebrew University of Jerusalem
Israel
Slots Available
Slots Available
Slots Available
http://novel-drugdelivery-systems.pharmaceuticalconferences.com/
@Pharmaceutica_C
6. ConferenceHighlights: Poster Presentation
Present your research poster at our conference
Benefits:
• Will be published in our conference proceedings and also
the conference book.
• Publication of entire article at 50% rebate in the respec-
tive subject journals.
• Posters will be evaluated by our Jury and the best poster
will be awarded a certificate.
Poster Specifications:
• Present numerical data in the form of graphs, rather than
tables (graphs make trends in the data much more ev-
ident).If data must be presented in table-form, keep it
Simple.
• Visuals should be simple and bold.
• Avoid acronyms and extensive mathematical notations as
much as possible.
• Posters with 800 words or less are perfect. Avoid submit-
ting compactly packed, high word-count posters.
• Organize your poster into subdivisions, e.g., Introduc-
tion, Methods, Results; Discussion, Conclusions, and
Literature Cited (avoid using too many citations).
• Use bright colours to enhance the detail.
• Text should be readable from five feet distance.
• Besides your project, the text could also include future
research plans or questions.
• Each poster should be approximately 1x1 M long.
• The title, contents and the author’s information should be
clearly visible from a distance of 1-2 feet.
Note: To secure a poster board and inclusion in the conference materials, your abstract must be submitted, approved and your
registration paid in full by February 15, 2017.
SPONSORSHIP OPPORTUNITIES
REGISTRATION & PRICING
HOTEL INFORMATION
Pre-Formulation & Formulation Aspects
Pharmacokinetics & Pharmacodynamics in Drugs
Drug Targeting and Design
Routes of Drug Delivery
Nanoparticulate Drug Delivery Systems
Nanotechnology in Drug Delivery
Pharmaceutical Nanotechnology
Smart Drug Delivery Systems
Biomaterials in Drug Delivery
Vaccine Drug Delivery Systems
Medical Devices for Drug Delivery
Peptides and Protein Drug Delivery
Global Drug Delivery Policy
Entrepreneurs Investment Meet
http://novel-drugdelivery-systems.pharmaceuticalconferences.com/
@Pharmaceutica_C
7. ConferenceHighlights: Young Researchers Forum
Come Let’s Bring a Transformation in the Scientific Society:
The Young Researchers Forum offers young researchers the
possibility to meet and discuss research topics and method-
ologies, share and develop ideas, learn from each other and
gain knowledge from senior researchers.
Benefits:
• Showcase your research through oral presentations.
• Learn about career development and the latest research
tools and technologies in your field.
• This forum will give pertinent and timely information
to those who conduct research and those who use and
benefit from research.
• Develop a foundation for collaboration among young
researchers.
• The forum will provide an opportunity for collegial
interaction with other young investigators and estab-
lished senior investigators across the globe.
• Interact and share ideas with both peers and mentors.
• Opportunity for young researchers to learn about the
research areas of their peers to increase their capacity
as multidisciplinary researchers.
• Actively distribute information and promote the bene-
fits of education and career matters.
For more info, PS: http://novel-drugdelivery-systems.pharmaceuticalconferences.com/young-researchers-forum.php
SPONSORSHIP OPPORTUNITIES
REGISTRATION & PRICING
HOTEL INFORMATION
Pre-Formulation & Formulation Aspects
Pharmacokinetics & Pharmacodynamics in Drugs
Drug Targeting and Design
Routes of Drug Delivery
Nanoparticulate Drug Delivery Systems
Nanotechnology in Drug Delivery
Pharmaceutical Nanotechnology
Smart Drug Delivery Systems
Biomaterials in Drug Delivery
Vaccine Drug Delivery Systems
Medical Devices for Drug Delivery
Peptides and Protein Drug Delivery
Global Drug Delivery Policy
Entrepreneurs Investment Meet
http://novel-drugdelivery-systems.pharmaceuticalconferences.com/
@Pharmaceutica_C
8. ConferenceHighlights: Venue Details:
SPONSORSHIP OPPORTUNITIES
REGISTRATION & PRICING
HOTEL INFORMATION
Pre-Formulation & Formulation Aspects
Pharmacokinetics & Pharmacodynamics in Drugs
Drug Targeting and Design
Routes of Drug Delivery
Nanoparticulate Drug Delivery Systems
Nanotechnology in Drug Delivery
Pharmaceutical Nanotechnology
Smart Drug Delivery Systems
Biomaterials in Drug Delivery
Vaccine Drug Delivery Systems
Medical Devices for Drug Delivery
Peptides and Protein Drug Delivery
Global Drug Delivery Policy
Entrepreneurs Investment Meet
http://novel-drugdelivery-systems.pharmaceuticalconferences.com/
HOTEL & TRAVEL INFORMATION
Conference Venue and Hotel:
Will be Updated Soon...
For more information visit:
http://novel-drugdelivery-systems.pharmaceuticalconferences.com/venue-hospitality.php
CONTACT
Renaldo Howell | Program Manager | Pharmaceutica 2017
E-pharmaceutica@conferenceseries.com
pharmaceutica@conferenceseries.net
Tel: +1-702-508-5200 Ext: 8046
Book your Accommodation
before the 15th
of December
avail a $100
waiver on the package.
For Reservations please contact above or
visit: http://novel-drugdelivery-systems.pharmaceuticalconferences.com/registration.php
@Pharmaceutica_C